Sequoia Financial Advisors LLC Has $399,000 Position in Henry Schein, Inc. (NASDAQ:HSIC)

Sequoia Financial Advisors LLC decreased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 4.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 5,830 shares of the company’s stock after selling 279 shares during the period. Sequoia Financial Advisors LLC’s holdings in Henry Schein were worth $399,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. Smartleaf Asset Management LLC grew its stake in shares of Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after acquiring an additional 143 shares in the last quarter. Guggenheim Capital LLC increased its stake in Henry Schein by 2.5% in the 4th quarter. Guggenheim Capital LLC now owns 6,428 shares of the company’s stock valued at $445,000 after buying an additional 159 shares during the last quarter. Metis Global Partners LLC lifted its position in shares of Henry Schein by 4.7% during the 4th quarter. Metis Global Partners LLC now owns 4,203 shares of the company’s stock worth $291,000 after buying an additional 187 shares in the last quarter. UMB Bank n.a. boosted its stake in shares of Henry Schein by 23.2% in the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company’s stock worth $73,000 after buying an additional 201 shares during the last quarter. Finally, Sanctuary Advisors LLC grew its holdings in shares of Henry Schein by 5.0% in the fourth quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company’s stock valued at $294,000 after acquiring an additional 203 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Ratings Changes

Several brokerages have commented on HSIC. Barrington Research lowered their price objective on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating on the stock in a research report on Tuesday, May 6th. Wall Street Zen cut shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, April 17th. Piper Sandler dropped their price objective on Henry Schein from $83.00 to $77.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 30th. Finally, Wells Fargo & Company decreased their target price on Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 6th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $79.30.

Henry Schein Price Performance

Shares of HSIC opened at $74.48 on Thursday. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.38 and a quick ratio of 0.75. The stock has a 50 day simple moving average of $70.34 and a two-hundred day simple moving average of $71.18. The firm has a market cap of $9.07 billion, a P/E ratio of 23.28, a P/E/G ratio of 2.40 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.04. The company had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a return on equity of 14.87% and a net margin of 3.21%. Henry Schein’s quarterly revenue was down .1% compared to the same quarter last year. During the same period in the prior year, the business posted $1.10 EPS. On average, analysts forecast that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.